Market Overview

Sanofi Buys OTC Antacid Rolaids from J&J's McNeil-PPC

Share:
Related SNY
Regeneron Pharmaceuticals Gains A Bull Ahead Of Earnings
Earnings Scheduled For November 2, 2017
A Simple Way To Analyze Berkshire Hathaway Holdings (Seeking Alpha)
Related JNJ
Stocks Going Ex Dividend The Fifth Week Of November
Pharma ETFs Down Post Q3 Earnings
A Simple Way To Analyze Berkshire Hathaway Holdings (Seeking Alpha)

Sanofi (NYSE : SNY) today announced that its US Consumer Healthcare Division, Chattem, Inc., completed the acquisition of the worldwide rights to the Rolaids^® brand from McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.

Posted-In: News M&A

 

Related Articles (JNJ + SNY)

View Comments and Join the Discussion!

Partner Center